Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

EU must tackle clinical trials shortfalls as current lack of evidence is "appalling"

This article was originally published in Clinica

Executive Summary

With devices becoming increasingly complex, Competent Authorities must ensure there are sufficiently well-trained experts at Notified Body level, particularly for assessing innovative devices and for clinical trials. But authorities are facing difficult resource issues and finding experts is a real challenge. Dr Susanne Ludgate of the UK MHRA told Amanda Maxwell where the problems lie, and what she believes to be the solutions

Advertisement

Topics

UsernamePublicRestriction

Register